五例<strong>cblX</strong>型甲基丙二酸血症患儿的临床特征及基因型分析

doi:10.3724/zdxbyxb-2022-0194

浙江大学学报（医学版）

2022, Vol. 51

Issue (3): 298-305 DOI: 10.3724/zdxbyxb-2022-0194

专题报道

五例cblX型甲基丙二酸血症患儿的临床特征及基因型分析

王斐¹,梁黎黎²,凌诗颖²,于玥²,陈婷²,徐峰²,龚珠文²,韩连书^2,*(

)

1.上海市儿童医院上海交通大学医学院附属儿童医院内分泌科，上海 200062
2.上海交通大学医学院附属新华医院上海市儿科医学研究所小儿内分泌遗传代谢科，上海 200092

Clinical characteristics and genotype analysis of five infants with cblX type of methylmalonic acidemia

WANG Fei¹,LIANG Lili²,LING Shiying²,YU Yue²,CHEN Ting²,XU Feng²,GONG Zhuwen²,HAN Lianshu^2,*(

)

1. Department of Endocrinology, Shanghai Children’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200062, China;
2. Department of Pediatric Endocrinology and Genetic Metabolism, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Institute for Pediatric Research, Shanghai 200092, China

全文: PDF(3779 KB)

HTML( 2 )

摘要：

目的：探讨钴胺素（cbl）X型甲基丙二酸血症（MMA）患儿的临床表型及基因型特点。方法：收集2016至2020年在上海交通大学医学院附属新华医院和上海市儿童医院就诊的5例cblX型MMA患儿的临床资料。采用串联质谱法检测血酰基肉碱水平，气相色谱–质谱法检测尿有机酸，全外显子基因测序法检测致病基因，并利用生物信息学分析方法预测新突变对三维蛋白质结构的影响。结果：5例cblX型MMA确诊患儿，男性4例，女性1例，发病年龄为出生后0~6个月。4例男性患儿的主要临床表现为顽固性癫痫、智力运动发育落后，代谢异常均表现为轻度血同型半胱氨酸水平增高，其中伴尿甲基丙二酸轻度升高3例，伴血丙酰基肉碱（C3）、C3/乙酰基肉碱（C2）升高1例；基因检测发现2例携带宿主细胞因子C1（HCFC1）已知基因突变c.344C>T（p.A115V），另外2例携带新的致病基因突变，分别为c.92G>A（p.R31Q）和c.166G>C（p.V56L）。这三种基因突变均位于HCFC1蛋白的Kelch结构域中。1例女性患儿携带c.3731G>T（p.R1244L）突变，临床症状较轻，仅尿甲基丙二酸轻度升高。结论：cblX型MMA患儿的临床表现多为顽固性癫痫、智力运动发育落后等严重的神经症状，代谢异常表现为血同型半胱氨酸伴甲基丙二酸（尿甲基丙二酸或/和血C3、C3/C2）升高，临床和生化表型呈分离现象，需要结合基因检测结果诊断。

关键词： 甲基丙二酸血症; cblX型; 同型半胱氨酸; X连锁; 宿主细胞因子C1

Abstract:

Objective: To investigate the clinical and genetic characteristics of infants with cobalamin (cbl) X type of methylmalonic acidemia (MMA). Methods: The clinical data of 5 infants with cblX type of MMA diagnosed in Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine and Shanghai Children’s Hospital from the year 2016 to 2020 were collected. The levels of blood acylcarnitines were detected by tandem mass spectrometry, the levels of urinary organic acids were detected by gas-chromatography mass spectrometry, the pathogenic genes were detected by whole exon gene sequencing, and the effect of new pathogenic mutations on three-dimensional protein structure was predicted by bioinformatics analysis. Results: Five infants with cblX type were diagnosed, including 4 males and 1 female, and the onset age was 0–6?months. The main clinical manifestations of 4 males were intractable epilepsy, mental and motor retardation, metabolic abnormalities presented mild increase of blood homocysteine level. Among them, 3 cases were accompanied by slight increase of urinary methylmalonic acid, and 1 case was accompanied by increase of blood propionylcarnitine (C3) and C3/acetylcarnitine (C2). Gene detection found that 2 cases carried a same hemizygous mutation c.344C>T (p.A115V) ofHCFC1 gene, which was the most reported mutation, and the other 2 cases carried novel pathogenic mutations, c.92G>A (p.R31Q) and c.166G>C (p.V56L). These 3 gene mutations located in the Kelch domain of HCFC1 protein. One female infant carried a benign mutation of c.3731G>T (p.R1244L). Her clinical symptoms were mild, and only the urinary methylmalonic acid was slightly increased.Conclusions: The clinical manifestations of children with cblX type of MMA are intractable epilepsy, mental and motor retardation, and other serious neurological symptoms. Their metabolic abnormalities present the increase of blood homocysteine with methylmalonic acid (urinary methylmalonic acid or/and blood C3, C3/C2). The clinical and biochemical phenotypes are separated, so the diagnosis should be in combination with the results of gene testing.

Key words: Methylmalonic acidemia Cobalamin X type Homocysteine X-linked Host cell factor C1

收稿日期: 2022-04-20 出版日期: 2022-09-21

CLC:

R725.8

基金资助: 上海市卫生健康委员会科研项目（202140346）；上海申康医院发展中心临床三年行动计划（SHDC2020CR6028）

通讯作者: 韩连书 E-mail: hanlianshu@xinhuamed.com.cn

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	王斐
	梁黎黎
	凌诗颖
	于玥
	陈婷
	徐峰
	龚珠文
	韩连书

引用本文:

王斐,梁黎黎,凌诗颖,于玥,陈婷,徐峰,龚珠文,韩连书. 五例cblX型甲基丙二酸血症患儿的临床特征及基因型分析[J]. 浙江大学学报（医学版）, 2022, 51(3): 298-305.

WANG Fei,LIANG Lili,LING Shiying,YU Yue,CHEN Ting,XU Feng,GONG Zhuwen,HAN Lianshu. Clinical characteristics and genotype analysis of five infants with cblX type of methylmalonic acidemia. J Zhejiang Univ (Med Sci), 2022, 51(3): 298-305.

链接本文:

https://www.zjujournals.com/med/CN/10.3724/zdxbyxb-2022-0194 或 https://www.zjujournals.com/med/CN/Y2022/V51/I3/298

表 1 五例cblX型甲基丙二酸血症患儿的临床表型及基因型特征

图 1 宿主细胞因子C1结构域及4种基因突变的定位

表 2 基因3种新突变致病性预测分析

图 2 基因3种新突变的蛋白分子结构模型HCFC1A： c.92G>A （p.R31Q）野生型；B： c.92G>A （p.R31Q）突变型；C： c.166G>C （p.V56L）野生型；D： c.166G>C （p.V56L）突变型；E： c.3731G>T （p.R1244L）野生型；F： c.3731G>T （p.R1244L）突变型. HCFC1：宿主细胞因子C1.

1	YUH C, SLOANJ L, SCHARERG, et al.An X-linked cobalamin disorder caused by mutations in transcriptional coregulator HCFC1[J]Am J Hum Genet, 2013, 93( 3): 506-514. doi: 10.1016/j.ajhg.2013.07.022
2	CASTROV L, QUINTANAA M. The role of HCFC1 in syndromic and non-syndromic intellectual disability[J]Med Res Arch, 2020, 8( 6): 10.18103/mra.v8i6.2122. doi: 10.18103/mra.v8i6.2122
3	李东晓, 刘玉鹏, 丁　圆, 等. 转录辅助调节因子HCFC1突变致罕见X连锁甲基丙二酸尿症CblX型一家系报告[J]. 临床儿科杂志, 2016, 34(3): 212-216 LI Dongxiao, LIU Yupeng, DING Yuan, et al. A pedigree of a rare Cb1X type X-linked methylmalonic acidemia due to transcriptional co-regulator HCFC1 mutation[J]. Journal of Clinical Pediatrics, 2016, 34(3): 212-216. (in Chinese)
4	沈亚平, 胡真真, 杨建滨, 等. 串联质谱法检测结果阴性的甲基丙二酸血症合并同型半胱氨酸血症cblX型患儿一例[J]. 浙江大学学报(医学版), 2021, 50(6): 795-798 SHENYaping, HUZhenzhen, YANGJianbin, et al.A case of methylmalonic acidemia and homocysteinemia cblX type with negative tandem mass spectrometry testing[J]. Journal of Zhejiang University (Medical Science)，2021, 50(6): 795-798. (in Chinese)
5	韩连书, 叶　军, 邱文娟, 等. 串联质谱联合气相色谱-质谱检测遗传性代谢病[J]. 中华医学杂志, 2008, 88(30): 2122-2126 HAN Lianshu, YE Jun, QIU Wenjuan, et al. Diagnosis of inborn errors of metabolism using tandem mass spectrometry and gas chromatography mass spectrometry[J]. National Medical Journal of China, 2008, 88(30): 2122-2126. (in Chinese)
6	JULIENE, HERRW. Proteolytic processing is necessary to separate and ensure proper cell growth and cytokinesis functions of HCF-1[J]EMBO J, 2003, 22( 10): 2360-2369. doi: 10.1093/emboj/cdg242
7	MAZARSR, GONZALEZ-DE-PEREDOA, CAYROLC, et al.The THAP-zinc finger protein THAP1 associates with coactivator HCF-1 and O-GlcNAc transferase[J]J Biol Chem, 2010, 285( 18): 13364-13371. doi: 10.1074/jbc.M109.072579
8	SLOAN J L, CARRILLO N, ADAMS D, et al. Disorders of intracellular cobalamin metabolism[EB/OL]. （2018-09-06）[2022-03-20]. https://mobt3ath.com/uplode/books/book-76518.pdf
9	WANGF, HANL, YANGY, et al.Clinical, biochemical, and molecular analysis of combined methylmalonic acidemia and hyperhomocysteinemia (cblC type) in China[J]J Inherit Metab Dis, 2010, 33( S3): 435-442. doi: 10.1007/s10545-010-9217-0
10	WATKINSD, ROSENBLATTD S. Inborn errors of cobalamin absorption and metabolism[J]Am J Med Genet, 2011, 157( 1): 33-44. doi: 10.1002/ajmg.c.30288
11	MICHAUDJ, PRAZV, JAMES FARESSEN, et al.HCFC1 is a common component of active human CpG-island promoters and coincides with ZNF143, THAP11, YY1, and GABP transcription factor occupancy[J]Genome Res, 2013, 23( 6): 907-916. doi: 10.1101/gr.150078.112
12	BHUIYANT, WARIDELP, KAPURIAV, et al.Distinct OGT-binding sites promote HCF-1 cleavage[J/OL]PLoS One, 2015, 10( 8): e0136636. doi: 10.1371/journal.pone.0136636
13	QUINTANAA M, YUH C, BREBNERA, et al.Mutations in THAP11 cause an inborn error of cobalamin metabolism and developmental abnormalities[J]Hum Mol Genet, 2017, 26( 15): 2838-2849. doi: 10.1093/hmg/ddx157
14	HUANGL, JOLLYL A, WILLIS-OWENS, et al.A noncoding, regulatory mutation implicates HCFC1 in nonsyndromic intellectual disability[J]Am J Hum Genet, 2012, 91( 4): 694-702. doi: 10.1016/j.ajhg.2012.08.011
15	GÉRARDM, MORING, BOURILLONA, et al.Multiple congenital anomalies in two boys with mutation in HCFC1 and cobalamin disorder[J]Eur J Med Genet, 2015, 58( 3): 148-153. doi: 10.1016/j.ejmg.2014.12.015
16	JOLLYL A, NGUYENL S, DOMINGOD, et al.HCFC1 loss-of-function mutations disrupt neuronal and neural progenitor cells of the developing brain[J]Hum Mol Genet, 2015, 24( 12): 3335-3347. doi: 10.1093/hmg/ddv083
17	KOUFARISC, ALEXANDROUA, TANTELESG A, et al.A novel HCFC1 variant in male siblings with intellectual disability and microcephaly in the absence of cobalamin disorder[J]BioMed Rep, 2016, 4( 2): 215-218. doi: 10.3892/br.2015.559
18	TARPEYP S, SMITHR, PLEASANCEE, et al.A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation[J]Nat Genet, 2009, 41( 5): 535-543. doi: 10.1038/ng.367
19	WONGKITTICHOTEP, WEGNERD J, SHINAWIM S. Novel exon-skipping variant disrupting the basic domain of HCFC1 causes intellectual disability without metabolic abnormalities in both male and femalepatients[J]J Hum Genet, 2021, 66( 7): 717-724. doi: 10.1038/s10038-020-00892-9
20	MINOCHAS, VILLENEUVED, PRAZV, et al.Rapid recapitulation of nonalcoholic steatohepatitis upon loss of host cell factor 1 function in mouse hepatocytes[J/OL]Mol Cell Biol, 2019, 39( 5): e00405. doi: 10.1128/mcb.00405-18
21	于　玥, 凌诗颖, 帅瑞雪, 等. 720例甲基丙二酸血症MMACHC基因c.609G>A突变患者临床特征及随访分析[J].浙江大学学报(医学版), 2021, 50(4): 436-443 YUYue, LINGShiying, SHUAIRuixue, et al.Clinical features and outcomes of patients with cblC type methylmalonic acidemia carrying MMACHC gene c.609G>A mutation[J]. Journal of Zhejiang University (Medical Science), 2021, 50(4): 436-443. (in Chinese)

[1]	沈亚平,胡真真,杨建滨,杨茹莱,黄新文. 串联质谱法检测结果阴性的甲基丙二酸血症合并同型半胱氨酸血症cblX型患儿一例[J]. 浙江大学学报（医学版）, 2021, 50(6): 795-798.
[2]	于玥,凌诗颖,帅瑞雪,邱文娟,张惠文,梁黎黎,季文君,刘宇超,顾学范,韩连书. 720例甲基丙二酸血症MMACHC基因c.609G>A突变患者临床特征及随访分析[J]. 浙江大学学报（医学版）, 2021, 50(4): 436-443.
[3]	郑良荣，朱建华，张力. 同型半胱氨酸对大鼠血管平滑肌细胞核转录因子κB活性的影响[J]. 浙江大学学报（医学版）, 2004, 33(3): 255-257.
[4]	胡申江. 重视动脉粥样硬化"非传统"危险因素的研究[J]. 浙江大学学报（医学版）, 2002, 31(5): 313-315.

Viewed

Full text

Abstract

Cited

Shared

Discussed